AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
New TB vaccine now in Phase I tests.
2004 APR 7 - (NewsRx.com & NewsRx.net) -- A genetically engineered vaccine aimed at preventing tuberculosis was administered to volunteers at St. Louis University, part of a clinical trial that is the first-ever human testing of the vaccine known as rBCG30.
Some 2 billion people, about one-third of the world's population, are believed infected with the TB pathogen. About 2 million people die annually and the World Health Organization estimates that TB deaths will reach 36 million over the next 2 decades. TB is the leading killer of people with AIDS.
An existing vaccine that has been in use for decades is most useful to protect infants, but the effectiveness wears off as people age.
The rBCG30 vaccine being tested at St. Louis University has been more successful in preliminary tests, university officials said. Dr. Daniel F. ...
- German starts clinical development of a new TB vaccine.
- Newspaper article from: Vaccine Weekly April 14, 2004 700+ words
...Albrecht Laufer. "Therefore, a successful TB vaccine has considerable economic potential." This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...
- First U.S. TB vaccine trial in 60 years begins.
- Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Indeed, this is the first new TB vaccine to be tested in our country...The currently available TB vaccine, called BCG, offers some...This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com &...
- A novel TB vaccine developed to combat a complex pathogen.
- Newspaper article from: Vaccine Weekly March 26, 2003 700+ words
...published their study in Immunology Letters (A novel TB vaccine; strategies to combat a complex pathogen. Immunol Lett...Mycobacterium tuberculosis Vaccine. This article was prepared by Vaccine Weekly editors from staff and other reports.
- Rethinking TB vaccine strategy.
- Newspaper article from: Vaccine Weekly July 14, 2004 700+ words
...incomplete initial protection to allow a better chance of controlling this major scourge. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
- New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South...
- Press release article from: Business Wire April 22, 2009 700+ words
...TOWN, South Africa -- The Aeras Global TB Vaccine Foundation, the Oxford-Emergent Tuberculosis...concept clinical trial of a promising new TB vaccine developed at the University of Oxford...of-concept trial of a new preventive TB vaccine in infants in more than 80 years. ...
- Aeras and Statens Serum Institut Enter Into Collaboration Agreement to Develop...
- Press release article from: PR Newswire March 30, 2005 700+ words
...30 /PRNewswire/ -- The Aeras Global TB Vaccine Foundation of Bethesda, Maryland and...development of SSI's tuberculosis (TB) vaccine, HyVac4. Aeras and SSI will form a...the agreement SSI's subunit HyVac4 TB vaccine candidate will be developed as a booster...
- GlaxoSmithKline Biologicals and Aeras Global TB Vaccine Foundation Partner to...
- Press release article from: PR Newswire October 20, 2005 700+ words
...GSK Biologicals) and the Aeras Global TB Vaccine Foundation (Aeras) today announced...for developing a safe and effective TB vaccine," said Dr. Jerald Sadoff, CEO of the Aeras Global TB Vaccine Foundation. "Cooperation between the...
- AERAS/CRUCELL TO DEVELOP TB VACCINE.
- Newspaper article from: Worldwide Biotech May 1, 2004 700+ words
...The Netherlands, and the Aeras Global TB Vaccine Foundation of Bethesda, Maryland, have...development milestones, for development of TB vaccine candidates. The Crucell-Aeras TB vaccine program will focus on improvement of the...
- Aeras partners with Crucell to develop TB vaccine.
- News wire article from: Europe Intelligence Wire March 24, 2004 700+ words
...Euronext, NASDAQ: CRXL) and the Aeras Global TB Vaccine Foundation of Bethesda, Maryland, announced...development milestones, for development of TB vaccine candidates. The Crucell-Aeras TB vaccine program will focus on improvement of the...
- Aeras Receives CDC Funding to Develop TB Vaccine Trial Sites in India; 3 year,...
- Press release article from: PR Newswire September 17, 2004 700+ words
...17 /PRNewswire/ -- Aeras Global TB Vaccine Foundation today announced a $925...the serious shortfall in international TB vaccine funding and will hasten the day when...early childhood. Although spending on TB vaccine research accounts for only a small fraction...
Source: HighBeam Research, New TB vaccine now in Phase I tests.